ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04668	TNF signaling pathway	22/238	120/7206	3.53504015081e-11
ko04621	NOD-like receptor signaling pathway	25/238	157/7206	3.84370091846e-11
ko04380	Osteoclast differentiation	22/238	134/7206	3.33182523558e-10
ko04217	Necroptosis	22/238	178/7206	7.54220088347e-08
ko04210	Apoptosis	22/238	180/7206	9.23556894259e-08
ko05164	Influenza A	20/238	167/7206	5.092677065e-07
ko05133	Pertussis	14/238	87/7206	7.92428259127e-07
ko04060	Cytokine-cytokine receptor interaction	21/238	191/7206	1.09979873546e-06
ko04064	NF-kappa B signaling pathway	14/238	96/7206	2.6898267146e-06
ko05132	Salmonella infection	14/238	98/7206	3.45779547929e-06
ko04620	Toll-like receptor signaling pathway	14/238	100/7206	4.415242446e-06
ko04657	IL-17 signaling pathway	13/238	87/7206	4.67065241755e-06
ko04623	Cytosolic DNA-sensing pathway	9/238	41/7206	5.59140389507e-06
ko05152	Tuberculosis	19/238	187/7206	1.16548657904e-05
ko04660	T cell receptor signaling pathway	15/238	124/7206	1.25731012281e-05
ko05131	Shigellosis	12/238	82/7206	1.36125597149e-05
ko05161	Hepatitis B	18/238	173/7206	1.43766380315e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	19/238	191/7206	1.58024995434e-05
ko05134	Legionellosis	11/238	74/7206	2.69094754094e-05
ko04115	p53 signaling pathway	11/238	74/7206	2.69094754094e-05
ko04662	B cell receptor signaling pathway	12/238	88/7206	2.8311485258e-05
ko05168	Herpes simplex infection	18/238	182/7206	2.87748639132e-05
ko05142	Chagas disease (American trypanosomiasis)	14/238	130/7206	9.04293409446e-05
ko04630	Jak-STAT signaling pathway	14/238	132/7206	0.000106802501206
ko04624	Toll and Imd signaling pathway	8/238	49/7206	0.000175784486103
ko05120	Epithelial cell signaling in Helicobacter pylori infection	11/238	92/7206	0.000204967766037
ko05145	Toxoplasmosis	13/238	126/7206	0.00024841205562
ko04932	Non-alcoholic fatty liver disease (NAFLD)	16/238	182/7206	0.000319489452133
ko05100	Bacterial invasion of epithelial cells	11/238	99/7206	0.000392253417384
ko04933	AGE-RAGE signaling pathway in diabetic complications	13/238	135/7206	0.000489285113848
ko05162	Measles	12/238	120/7206	0.00057122107091
ko05323	Rheumatoid arthritis	10/238	89/7206	0.000657552328552
ko04666	Fc gamma R-mediated phagocytosis	12/238	122/7206	0.000663505965734
ko04722	Neurotrophin signaling pathway	14/238	160/7206	0.000789865453339
ko04215	Apoptosis - multiple species	7/238	47/7206	0.000798465083494
ko04622	RIG-I-like receptor signaling pathway	8/238	62/7206	0.000910849056404
ko05160	Hepatitis C	13/238	153/7206	0.00158268273027
ko04020	Calcium signaling pathway	1/238	265/7206	0.00236293702918
ko04080	Neuroactive ligand-receptor interaction	4/238	423/7206	0.00281373121114
ko01524	Platinum drug resistance	8/238	76/7206	0.00341916750673
ko04062	Chemokine signaling pathway	15/238	201/7206	0.00365552782899
ko05130	Pathogenic Escherichia coli infection	8/238	77/7206	0.00370953024009
ko04931	Insulin resistance	11/238	137/7206	0.00549331549855
ko05210	Colorectal cancer	8/238	86/7206	0.00726180405459
ko04144	Endocytosis	21/238	342/7206	0.00737338473797
ko05418	Fluid shear stress and atherosclerosis	13/238	173/7206	0.0074364049138
ko04920	Adipocytokine signaling pathway	8/238	89/7206	0.00888541815838
ko05140	Leishmaniasis	7/238	75/7206	0.0115559728113
ko04658	Th1 and Th2 cell differentiation	8/238	96/7206	0.0137138732613
ko04010	MAPK signaling pathway	18/238	321/7206	0.024480394284
ko05203	Viral carcinogenesis	16/238	277/7206	0.0252029829561
ko04672	Intestinal immune network for IgA production	4/238	37/7206	0.0326461005792
ko04142	Lysosome	10/238	151/7206	0.0334797776225
ko04670	Leukocyte transendothelial migration	10/238	151/7206	0.0334797776225
ko05321	Inflammatory bowel disease (IBD)	5/238	56/7206	0.0367184120473
ko04650	Natural killer cell mediated cytotoxicity	7/238	97/7206	0.0408802261148
ko05020	Prion diseases	4/238	40/7206	0.0418692418372
ko05146	Amoebiasis	7/238	99/7206	0.0448616739558
ko04550	Signaling pathways regulating pluripotency of stem cells	1/238	165/7206	0.0453199690177